Royalty Pharmaìs Acquisition of Royalty Interest from GSK

Dechert advised Royalty Pharma on the deal.Royalty Pharma plc executed its acquisition of a royalty interest in the cabozantinib products Cabometyx and Cometriq from GlaxoSmithKline (GSK)…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now